Robust data on the impact of the COVID-19 pandemic on mortality in Africa are relatively
scarce. Using data from two well-characterized populations in Kenya we aimed to estimate …

Considering the early inequity in global COVID-19 vaccine distribution, we compared the
level of population immunity to SARS-CoV-2 with vaccine uptake and refusal between rural …

Initial transmission of severe acute respiratory syndrome virus-2 (SARS-CoV-2) was highest
in densely populated regions of Kenya. Transmission gradually trickled down to the less …

Background SARS-CoV-2 has extensively spread in cities and rural communities, and
studies are needed to quantify exposure in the population. We report seroprevalence of …

Background Most of the studies that have informed the public health response to the COVID-
19 pandemic in Kenya have relied on samples that are not representative of the general …

Background The InBios SCoV-2 Detect TM IgG ELISA (InBios) and the in-house KWTRP
ELISA (KWTRP) have both been used in the estimation of SARS-CoV-2 seroprevalence in …

Background Pregnant women are a vulnerable population to COVID-19 given an increased
susceptibility to severe SARS-CoV-2 infection and pregnancy complications. However, few …

Introduction Refugee settings may increase the risk of SARS-CoV-2 infection and death, yet
data on the response to the pandemic in these populations is scarce. Methods We describe …

Background Very limited information is available on SARS-CoV-2 seroprevalence in infants
in sub-Saharan countries. Objective In this study, we aimed to determine the rate and the …

The Kenya Multi Site Serosurveillance (KEMIS) collaboration set out to implement an
integrated, nationally representative, population-based program of serological surveillance …